We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Results of Pivotal Catheter Study Published

By MedImaging International staff writers
Posted on 18 Jul 2017
Print article
Image: The Bio2 Medical Angel catheter intended for PE prophylaxis in trauma patients, with contraindication to anticoagulation (Photo courtesy of Bio2 Medical).
Image: The Bio2 Medical Angel catheter intended for PE prophylaxis in trauma patients, with contraindication to anticoagulation (Photo courtesy of Bio2 Medical).
The results of a pivotal study for the evaluation of a combined inferior vena cava filter and central venous catheter to prevent pulmonary embolism in critical trauma patients have been published.

The single-arm, multicenter clinical trial showed that the combined catheter resulted in a substantial reduction in clinically significant, as well as fatal cases of Pulmonary Embolism (PE), in critically ill patients.

The combined Angel Inferior Vena Cava (IVC) filter and Central Venous (CV), FDA-cleared catheter was developed by Bio2 Medical (Golden, CO, USA), and the results of the study were published in the June 29, 2017, issue of the Journal of Vascular and Interventional Radiology (JVIR). The catheter was inserted in the Intensive Care Unit (ICU), at the bedside, without fluoroscopy, and retrieved safely, before patient discharge. The study cohort included 163 critically ill patients contraindicated to anticoagulation, all with a high risk of acute PE, from 20 Intensive Care Units (ICUs) in the US.

The results indicated that the Angel Catheter prevented the occurrence of PEs in 11% (14) of 129 patients who had a pre-removal cavogram. The Angel Catheter also impacted PE-related spending reducing the cost of IVC filter removal, and the Interventional Radiology (IR) suite time needed.

Primary investigator of the study, Victor F. Tapson, MD, said, "Acute PE kills more than 100,000 Americans every year, and many more around the world. This study of a combined IVC filter/central venous catheter was the culmination of a panel of dedicated investigators with careful guidance by the FDA. The efficacy and safety of the device, simple bedside placement, and the need to remove it before discharge make it very appealing. Nearly the entire cohort had crucial, yet short-term filter needs so that discharge without a filter was preferred."

Related Links:
Bio2 Medical

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Mammography System
MAMMOVISTA B.smart
New
Portable X-Ray Unit
AJEX240H
New
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.